Literature DB >> 56431

The significance of perivascular infiltrations in multiple sclerosis.

A Guseo, K Jellinger.   

Abstract

143 autopsy cases of multiple sclerosis (19 acute and 124 chronic cases) were analysed histologically for the extent of active demyelination and the degree of infiltration within and outside the demyelinating lesions and in the leptomeninges. The results were compared with the duration of the illness. Infiltrations were found in 60% of all cases but more often (74%) in those with active demyelination. Inflammatory lesions outside demyelinating foci were observed in 27% of the total, and in 80% of them active demyelination was present. Inflammatory lesions in the meninges were present in 41% of the total and in 80% of these were accompanied by active demyelination. The duration of illness correlated with decreasing severity of active demyelination and of perivascular infiltration. Patients treated with cortico-steroids and/or immunosuppressive substances showed no or only moderate inflammatory lesions. The duration of illness in both these groups was significantly longer than the average of untreated patients. The significance of these pathological findings for the CSF cytology in multiple sclerosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 56431     DOI: 10.1007/bf00312463

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  The onset and progression of the lesion in multiple sclerosis.

Authors:  C W Adams
Journal:  J Neurol Sci       Date:  1975-06       Impact factor: 3.181

2.  Neurological diseases with elevation of cerebrospinal fluid gamma globulin: a critical review.

Authors:  D H HARTER; M D YAHR; E A KABAT
Journal:  Trans Am Neurol Assoc       Date:  1962

3.  [Acute fatal demyelinizing encephalitis after repeated injections of dry brain cells].

Authors:  K JELLINGER; F SEITELBERGER
Journal:  Klin Wochenschr       Date:  1958-05-01

4.  [Not Available].

Authors:  J SAYK; R M SCHMIDT
Journal:  Arztl Wochensch       Date:  1956-09-07

5.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.

Authors:  C Jersild; T Fog; G S Hansen; M Thomsen; A Svejgaard; B Dupont
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

6.  Cell-mediated demyelination of peripheral nerve in tissue culture.

Authors:  B G Arnason; G F Winkler; N M Hadler
Journal:  Lab Invest       Date:  1969-07       Impact factor: 5.662

7.  Experimental allergic encephalomyelitis: demyelinating activity of serum and sensitized lymph node cells on cultured nerve tissues.

Authors:  M B Bornstein; H Iwanami
Journal:  J Neuropathol Exp Neurol       Date:  1971-04       Impact factor: 3.685

8.  B lymphocytes bearing immunoglobulins in multiple sclerosis.

Authors:  T Sekizawa; M Sasaki; K Kumagai; S Takase; S Nakamura
Journal:  Tohoku J Exp Med       Date:  1974-12       Impact factor: 1.848

9.  [Is there a characteristic cerebrospinal fluid cell picture in multiple sclerosis? The significance of large pyronine-staining round cells in the cerebrospinal fluid].

Authors:  W Schlote; W Roos
Journal:  Nervenarzt       Date:  1974-11       Impact factor: 1.214

10.  Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction.

Authors:  H M Wisniewski; B R Bloom
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  22 in total

1.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

Authors:  Yulin Ge; Meng Law; Glyn Johnson; Joseph Herbert; James S Babb; Lois J Mannon; Robert I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

Review 3.  B-cells and humoral immunity in multiple sclerosis. Implications for therapy.

Authors:  Sangjin Oh; Cornelia Cudrici; Takahiro Ito; Horea Rus
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  Cortical lesions in multiple sclerosis.

Authors:  Massimiliano Calabrese; Massimo Filippi; Paolo Gallo
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

Review 5.  Clinical implications of neuropathological findings in multiple sclerosis.

Authors:  Wolfgang Brück
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

6.  Perivascular iron deposition and other vascular damage in multiple sclerosis.

Authors:  C W Adams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

7.  Chronic encephalomyelitis presenting as chronic progressive myelopathy.

Authors:  T Yamamoto; J F Llena; E S Kim; A Hirano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

8.  An unusual form of measles meningoencephalitis. A report of two cases.

Authors:  I Derakhshan; A Shafii; J Lotfi; K Abbassioun; J J Scillian
Journal:  J Neurol       Date:  1979-09       Impact factor: 4.849

9.  Immunofluorescence studies of intra cytoplasmic immunoglobulin binding lymphoid cells (CILC) in the central nervous system. Report of 32 cases including 19 multiple sclerosis.

Authors:  J M Mussini; J J Hauw; R Escourolle
Journal:  Acta Neuropathol       Date:  1977-11-28       Impact factor: 17.088

Review 10.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.